C-reactive protein-albumin ratio is an independent prognostic predictor of tumor recurrence in stage IIIA-N2 lung adenocarcinoma patients

Lung Cancer. 2017 Dec:114:62-67. doi: 10.1016/j.lungcan.2017.11.002. Epub 2017 Nov 3.

Abstract

Objective: To systematically evaluate the prognostic value of nutrition/inflammation-based markers for recurrence-free survival (RFS) in pN2-stage IIIA lung adenocarcinoma patients.

Materials and methods: Data from 156 patients who had pathologically confirmed pN2-stage IIIA primary lung adenocarcinoma and received complete surgical resection from 2010 to 2014 were retrospectively analyzed. The data for Glasgow prognostic score (GPS), modified GPS (mGPS), high-sensitivity mGPS, C-reactive protein/albumin ratio (CAR), neutrophil/lymphocyte ratio, platelet/lymphocyte ratio, and prognostic nutritional index were analyzed. Univariate and multivariate Cox proportional-hazards regression analyses were used to identify the prognostic factors associated with RFS.

Results: The optimal cutoff value for the CAR was set at 0.6. A significant correlation was found between the CAR and RFS (P=0.001) by univariate analysis. Multivariate analysis between RFS and the factors selected from univariate analysis showed that ECOG performance status, pneumonectomy, multi-level N2, and high CAR were independent predictors of RFS.

Conclusion: The CAR was the best prognostic marker to predict tumor recurrence in pN2-stage IIIA lung adenocarcinoma patients among the 7 nutrition/inflammation-based markers. The preoperative CAR may identify patients with a high risk of postoperative tumor recurrence.

Keywords: C-reactive protein-albumin ratio; Inflammation; Lung adenocarcinoma; NSCLC stage IIIA; Nutrition; Prognostic marker.

MeSH terms

  • Adenocarcinoma / mortality
  • Adenocarcinoma / pathology*
  • Adenocarcinoma / surgery
  • Adenocarcinoma / therapy
  • Adenocarcinoma of Lung
  • Aged
  • Albumins / analysis*
  • Biomarkers / blood
  • Blood Platelets / pathology
  • C-Reactive Protein / analysis*
  • Chemoradiotherapy, Adjuvant / methods
  • Chemotherapy, Adjuvant / methods
  • Female
  • Humans
  • Inflammation / blood*
  • Inflammation / pathology
  • Lung Neoplasms / mortality
  • Lung Neoplasms / pathology*
  • Lung Neoplasms / surgery
  • Lung Neoplasms / therapy
  • Lymphocytes / pathology
  • Male
  • Middle Aged
  • Neoplasm Recurrence, Local / blood
  • Neoplasm Recurrence, Local / pathology*
  • Neoplasm Staging
  • Neutrophils / pathology
  • Nutrition Assessment
  • Predictive Value of Tests
  • Prognosis
  • Retrospective Studies

Substances

  • Albumins
  • Biomarkers
  • C-Reactive Protein